Stock Analysis on Net

UnitedHealth Group Inc. (NYSE:UNH)

$24.99

Statement of Comprehensive Income

Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

UnitedHealth Group Inc., consolidated statement of comprehensive income

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net earnings
Unrealized gains (losses) on investment securities during the period, net of tax
Reclassification adjustment for net realized (gains) losses included in net earnings, net of tax
Foreign currency translation gains (losses)
Reclassification adjustment for translation (gains) losses included in net earnings
Other comprehensive income (loss)
Comprehensive income
Comprehensive income attributable to noncontrolling interests
Comprehensive income attributable to UnitedHealth Group common shareholders

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


Net earnings exhibited a general upward trend from 2021 to 2023, increasing from US$17,732 million to US$23,144 million. However, a significant decline in net earnings occurred in 2024, falling to US$15,242 million, and continued in 2025 to US$12,807 million. Other comprehensive income also demonstrated volatility, with a substantial loss in 2021 and 2022, followed by gains in 2023 and 2024, before moderating in 2025. Comprehensive income, mirroring the net earnings trend, peaked in 2023 at US$24,510 million before decreasing in subsequent years.

Net Earnings Trend
The initial growth in net earnings between 2021 and 2023 suggests positive operational performance. The subsequent decline in 2024 and 2025 warrants further investigation to determine the underlying causes, which could include increased expenses, decreased revenues, or one-time events. The magnitude of the decline from the 2023 peak is considerable.
Unrealized Gains (Losses) on Investment Securities
Fluctuations in unrealized gains and losses on investment securities were observed throughout the period. A significant loss was recorded in 2022, followed by a substantial gain in 2023. The values in 2024 and 2025 were relatively small, but positive. These fluctuations indicate sensitivity to market conditions and investment portfolio performance.
Reclassification Adjustments
Reclassification adjustments, both for investment securities and foreign currency translation, introduce complexity to the overall comprehensive income picture. The large positive reclassification adjustment for translation in 2024, at US$4,214 million, significantly boosted other comprehensive income for that year. The absence of a corresponding adjustment in 2025 suggests this was a non-recurring item.
Foreign Currency Translation
Foreign currency translation gains and losses were variable. A substantial loss was recorded in 2021, followed by gains in 2022 and 2023. A loss was again recorded in 2024, and a smaller gain in 2025. This suggests exposure to currency fluctuations and their impact on financial results.
Comprehensive Income Attributable to Noncontrolling Interests
Comprehensive income attributable to noncontrolling interests consistently represented a negative value throughout the period, and increased in absolute value each year. This indicates that the noncontrolling interests are experiencing losses or distributions that reduce the overall comprehensive income attributable to the parent company.
Comprehensive Income Attributable to UnitedHealth Group Common Shareholders
The trend in comprehensive income attributable to common shareholders closely follows the trend in overall comprehensive income, reflecting the impact of the noncontrolling interests. The peak in 2023 and subsequent declines in 2024 and 2025 are consistent with the net earnings pattern.

Overall, the period demonstrates a complex financial performance. While initial growth was evident, the later years show a marked decline in profitability, coupled with significant volatility in other comprehensive income components. Further analysis is needed to understand the drivers behind these trends and their potential implications.